· Jeff Zimmerman, DVM, Ph.D., Iowa State University, Ames, Iowa
· “Proof of concept: Strategies to stabilize RNA viruses in oral fluids”
· Daniel Linhares, DVM, MBA, Ph.D., Iowa State University, Ames, Iowa
· “Predictive value of PRRSV qPCR results from sow tonsil-oral-scraping (TOSc) samples for neonatal litter PRRSV status”
· Alyssa Betlach, DVM, Ph.D., Swine Vet Center, St. Peter, Minnesota
· “Assessing the role of gilt-related risk factors for PRRSV time-to-low-prevalence”
Boehringer Ingelheim has supported more than 70 research projects since the GRANTS program’s inception in 2003. Across multiple evolutions of this program, more than $1.8 million has been given in support of the development of less costly, innovative diagnostic testing and sampling processes; identified more effective biosecurity practices; helped the industry better understand key diseases; and developed risk assessment tools, intervention programs, and vaccination strategies.
Applications for the 2024 GRANTS program will be open for submission in early 2024. For more information on how the GRANTS program is advancing the swine industry’s knowledge of diseases and new technology through game-changing research, tools and more, visit swineresearchawards.com.
Research content is solely the responsibility of the authors and does not necessarily represent the official views of the Swine Research and Technology Review Board or Boehringer Ingelheim.
About the Swine Research and Technology Review Board
The Swine Research and Technology Review Board, an independent group of swine veterinarians and researchers, selects GRANTS recipients annually. Board members for the 2023 award selection process include:
· Daryl Olsen, DVM, AMVC
· Montse Torremorell, DVM, Ph.D., University of Minnesota
· Darin Madson, DVM, Ph.D., JBS Live Pork
· William Hollis, DVM, Carthage Veterinary Service, Carthage Ltd.
· Emily McDowell, DVM, Veterinarian, Pipestone Veterinary Service
· Jessica Davenport, DVM, 2023 AASV Young Swine Veterinarian of the Year, JBS Live Pork
Source : Boehringer Ingelheim